NEW YORK (Reuters Health) – The combination of the cholesterol uptake inhibitor ezetimibe and a statin is more effective than a statin alone for reducing LDL cholesterol in…
NEW YORK (Reuters Health) – Lipid-lowering therapy reduces cardiovascular events and all-cause mortality in patients with atrial fibrillation, according to a post hoc analysis of the AFFIRM study.…
NEW YORK (Reuters Health) – Men with azoospermia are significantly more likely to carry cystic fibrosis gene mutations than men with other causes of infertility, according to research…
Protein energy malnutrition can cause death in post-operative and cancer patients. New protein-rich snacks can help remedy that situation, and offer a new solution for cancer patients undergoing…
NEW YORK (Reuters Health) – Patients with a textbook case of “typical” angina are no more likely than patients with atypical or nonanginal chest pain to have inducible…
NEW YORK (Reuters Health) – Patients with macroprolactinemia don’t need extensive exams or prolonged monitoring, according to a prospective study. As long as their monomeric prolactin concentration is…
NEW YORK (Reuters Health) – A single yearly oral dose of 500,000 international units of cholecalciferol (vitamin D) does not protect generally healthy older women from falls and…
NEW YORK (Reuters Health) – The dopamine agonist pramipexole relieves depressive symptoms in patients with Parkinson’s disease, according to a study published online May 10th in The Lancet…
NEW YORK (Reuters Health) – Mounting evidence suggests that preoperative prostate specific antigen (PSA) kinetics are a poor marker of disease progression. During active surveillance for low-risk, low-volume…
NEW YORK (Reuters Health) – An iPhone with dedicated software for evaluation of coronary CT angiography (CTA) is highly accurate for detecting and excluding significant stenosis, according to…